Alpine Immune Sciences Provides Corporate Update and Reports Full Year 2018 Financial Results
SEATTLE--(BUSINESS WIRE)--Mar 18, 2019--Alpine Immune Sciences, Inc. (Nasdaq:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for c…